ATE161580T1 - Von vitamin d-bindendem protein abgeleiteter makrophagen-aktivierender faktor - Google Patents

Von vitamin d-bindendem protein abgeleiteter makrophagen-aktivierender faktor

Info

Publication number
ATE161580T1
ATE161580T1 AT91917591T AT91917591T ATE161580T1 AT E161580 T1 ATE161580 T1 AT E161580T1 AT 91917591 T AT91917591 T AT 91917591T AT 91917591 T AT91917591 T AT 91917591T AT E161580 T1 ATE161580 T1 AT E161580T1
Authority
AT
Austria
Prior art keywords
binding protein
vitamin
protein derived
activate factor
derived macrophage
Prior art date
Application number
AT91917591T
Other languages
English (en)
Inventor
Nobuto Yamamoto
Original Assignee
Nobuto Yamamoto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobuto Yamamoto filed Critical Nobuto Yamamoto
Application granted granted Critical
Publication of ATE161580T1 publication Critical patent/ATE161580T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
AT91917591T 1990-08-31 1991-08-29 Von vitamin d-bindendem protein abgeleiteter makrophagen-aktivierender faktor ATE161580T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/576,248 US5177002A (en) 1989-11-20 1990-08-31 In vitro enzymatic conversion of glycosylated human vitamin D binding protein to a potent macrophage activating factor

Publications (1)

Publication Number Publication Date
ATE161580T1 true ATE161580T1 (de) 1998-01-15

Family

ID=24303582

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91917591T ATE161580T1 (de) 1990-08-31 1991-08-29 Von vitamin d-bindendem protein abgeleiteter makrophagen-aktivierender faktor

Country Status (9)

Country Link
US (1) US5177002A (de)
EP (1) EP0546096B1 (de)
JP (1) JP2596491B2 (de)
AT (1) ATE161580T1 (de)
AU (1) AU8654191A (de)
CA (1) CA2092720C (de)
DE (1) DE69128535T2 (de)
ES (1) ES2111002T3 (de)
WO (1) WO1992004459A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5326749A (en) * 1989-11-20 1994-07-05 Nobuto Yamamoto Macrophage activating factor from vitamin D binding protein
US5177001A (en) * 1989-11-20 1993-01-05 Nobuto Yamamoto In vitro enzymatic conversion of glycosylated mammalian vitamin D-binding protein to a potent macrophage activating factor
US5627029A (en) * 1991-05-03 1997-05-06 Genzyme Corporation Method for obtaining informative cells
US5691160A (en) * 1992-08-14 1997-11-25 Biogen, Inc. Effects of actin filaments of fibrin clot structure and lysis
US5641747A (en) * 1994-07-25 1997-06-24 Temple University-Of The Commonwealth System Of Higher Education Treatment of osteopetrotic diseases
US20060014143A1 (en) * 1995-06-07 2006-01-19 Nobuto Yamamoto Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
US6410269B1 (en) * 1995-06-07 2002-06-25 Nobuto Yamamoto Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
EP1280546A4 (de) * 2000-05-09 2005-02-23 Childrens Medical Center Methode und verbindung zur behandlung von angiogenese
CA2456843A1 (en) * 2001-08-14 2003-02-27 Statens Serum Institut A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine
JP5860401B2 (ja) * 2010-09-03 2016-02-16 森田薬品工業株式会社 新規Ｇｃグロブリンガラクトース脱糖体の製造方法
CN103547280B (zh) 2011-04-07 2017-06-09 艾弗兰纳特有限公司 用于药物组合物的巨噬细胞活化因子
AU2013323472B2 (en) * 2012-09-28 2018-07-05 Ellis KLINE Glycosidase regimen for treatment of infectious disease
US20160120946A1 (en) * 2013-06-09 2016-05-05 Efranat Ltd. Compositions comprising gc-macrophage activating factor and uses thereof
WO2019117295A1 (ja) * 2017-12-15 2019-06-20 公益財団法人神戸医療産業都市推進機構 活性型ＧｃＭＡＦの製造方法
AU2021398261A1 (en) * 2020-12-08 2023-07-06 Saisei Pharma Co., Ltd. Macrophage activator

Also Published As

Publication number Publication date
WO1992004459A1 (en) 1992-03-19
AU8654191A (en) 1992-03-30
CA2092720A1 (en) 1992-03-01
EP0546096A4 (de) 1994-04-27
DE69128535T2 (de) 1998-05-20
DE69128535D1 (de) 1998-02-05
EP0546096B1 (de) 1997-12-29
ES2111002T3 (es) 1998-03-01
JPH06503716A (ja) 1994-04-28
US5177002A (en) 1993-01-05
EP0546096A1 (de) 1993-06-16
JP2596491B2 (ja) 1997-04-02
CA2092720C (en) 1999-12-14

Similar Documents

Publication Publication Date Title
ATE161580T1 (de) Von vitamin d-bindendem protein abgeleiteter makrophagen-aktivierender faktor
NO872988D0 (no) Pattedyr-interleukin-4.
DE59005097D1 (de) Verwendung härtbarer Cycloaliphaten-Derivate in Dübelmassen.
DE3778006D1 (de) Hochreines, halbsynthetisches blutsurrogat.
IT8124109A0 (it) Produzione microbica di interferone di fibroblasti umani.
FI895346A0 (fi) Bindande proteiner.
ES2123515T3 (es) Antagonistas de citoquinas a base de proteinas virales aisladas.
TR22674A (tr) Su gecirmez derilerin veya kuerklerin ueretilmesine mahsus usul
DK0585939T3 (da) TNF-ligander
IT1231549B (it) Procedimento per la produzione di semilavorati di cuoio
ATE83761T1 (de) Grobkeramischer formkoerper, sowie dessen verwendung.
FI902389A7 (fi) Ahtopainemodifioitu, laskukompensoitu suoratoiminen paineensäädin
FI903366A7 (fi) Menetelmä erittäin puhtaan, ei tartuttavan antihemofiliatekijän valmis tamiseksi kromatografoinnilla
HUT43791A (en) Process for preparing vaccine against tick
AU599133B2 (en) Novel substituted (4.2.0.)bicyclooctane derivatives with valuable therapeutic properties
DK0685492T3 (da) Fremgangsmåde til fremstilling af molekylært ensartede hyperpolymere hæmoglobiner
SE8403929D0 (sv) Recombinant dna molecule, transformed microorganisms and process for producing penicillin v amidase
ES293286U (es) Base-soporte, de apoyos orientables independientes
ES1003268U (es) Diana perfeccionada
KR880010097U (ko) 테이블 부착용 적외선 난방램프
ES278173U (es) Estabilizador para tablas deslizadoras a vela
ATE83303T1 (de) Lichtleiste fuer schraenke, insbesondere fuer schlafzimmerschraenke.
ES284173U (es) Separador para canulaciones venosas quirurgicas efectuadas con ultrasonidos.
ES1015071U (es) Soporte para cuchillos y similares.
ES292983U (es) Placa-base perfeccionada, para morteros

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time